Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, David D.L. Bowtell et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian CancerEllen L. Goode, Naveena Singh, Matthew S. Block et al.|JAMA Oncology|2017Cited by 409
Prognostic gene expression signature for high-grade serous ovarian cancerJoshua Millstein, Scott D. Brown, Timothy Budden et al.|Annals of Oncology|2020Cited by 173
Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium studyAnna DeFazio, Martin Köbel, Jason Madore et al.|British Journal of Cancer|2014Cited by 113
A combination of the immunohistochemical markers CK7 and SATB2 is highly sensitive and specific for distinguishing primary ovarian mucinous tumors from colorectal and appendiceal metastasesNicola S. Meagher, Raghwa Sharma, Linyuan Wang et al.|Modern Pathology|2019Cited by 104